Compugen restructures AstraZeneca deal to boost cash coffers
Israeli drug discovery and development company Compugen (Nasdaq: CGEN; TASE: CGEN) today announced changes in its commercialization deal with ...
Israeli drug discovery and development company Compugen (Nasdaq: CGEN; TASE: CGEN) today announced changes in its commercialization deal with ...
Palo Alto Networks $25 billion acquisition of Israeli cybersecurity company CyberArk Software (Nasdaq: CYBR) could earn Israel's state coffers ...
© Copyright 2024 All Rights Reserved
See articles for original source and related links to external sites.
© Copyright 2024 All Rights Reserved
See articles for original source and related links to external sites.